Tim Shannon

Director at Vivace Therapeutics.

Raised on Vivace Therapeutics filings

$17.5M

of $35M offered across 1 Form D filing

Form D filings: 1
Teammates: 5
Last filing: Mar 12, 2025

Company

Vivace Therapeutics

Biotech · San Mateo, CA

Hippo pathway drugs for mesothelioma and solid tumors

Hippo pathway drugs for mesothelioma and solid tumors

Investors: 5
Still open: $17.5M

Investors: 5
Sector: Biotech
HQ: San Mateo, CA

Vivace Therapeutics filings

Vivace Therapeutics Form D filings
Filed	Security	Sold of offered	Filing
Mar 12, 2025	Equity	$17.5M/ $35M	Form D

EquityFiled Mar 12, 2025Form D
$17.5M/ $35M

Works with

Also named on Vivace Therapeutics filings

Shuang QiaoChief Executive Officer, Form D signerForm D signer Jake SimsonDirector Chenguang ZhouDirector Edward HuDirector Jun WuDirector